The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 98.00
Bid: 96.00
Ask: 100.00
Change: 0.00 (0.00%)
Spread: 4.00 (4.167%)
Open: 98.00
High: 98.00
Low: 98.00
Prev. Close: 98.00
EAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual & Interim Reports Publication & AGM Notice

4 Feb 2021 07:10

RNS Number : 9860N
Eco Animal Health Group PLC
04 February 2021
 

4 February 2021

ECO Animal Health Group plc ("the Company")

(AIM: EAH)

Annual Report and Accounts, Interim Report and Accounts

Annual General Meeting and General Meeting

ECO Animal Health Group plc announces the publication of the following documents ("The Documents") on the Company's website: www.ecoanimalhealthgroupplc.com/investor-relations.aspx.

 

· The Annual Report and Accounts for the year ended 31 March 2020;

· The Interim Accounts for the six months ended 30 September 2020;

· a Notice of Annual General Meeting to be held at 1.30 p.m. on 4 March 2021 and Form of Proxy;

· a Circular containing a Notice of a General Meeting to be held at 2.00 p.m. on 4 March 2021 and Form of Proxy to consider:

o the proposed adoption of a new deferred bonus plan for senior management;

o the proposed adoption of a new long term incentive plan for senior management; and

o amendment to the existing unapproved staff share option plan.

 

As a result of the physical meeting restrictions arising from the current COVID-19 pandemic, the Company's Annual General Meeting and General Meeting will be held as closed meetings at which only the minimum number of persons required to form the quorum will be formally present and shareholders may not attend. Accordingly, you are strongly encouraged to provide your voting by proxy to the Chairman of the meeting. Despite the Annual General Meeting ("AGM") and General Meeting ("GM") needing to be held as closed meetings, ECO Animal Health Group plc is committed to constructive engagement with all of its shareholders and shareholders are invited to submit questions relating to the business of the AGM and the GM by email to enquiries@ecoanimalhealth.com. Questions should be submitted by 1.30 p.m. on 26 February 2021 and the Company will ensure, to the extent practicable, that all queries receive a response prior to the AGM and GM.

 

Following publication of the Annual Report and Accounts for the year ended 31 March 2020 and the Interim Accounts for the six months ended 30 September 2020, application has been made for the restoration of trading in the Company's securities to AIM and restoration is anticipated for 7.30 a.m. today.

 

The Documents will be posted to shareholders on Friday 5 February 2021.

 

 

Contacts:

 

ECO Animal Health Group plc

Marc Loomes (CEO)

Christopher Wilks (CFO)

 

020 8447 8899

 

IFC Advisory

Graham Herring

Zach Cohen

 

020 3934 6630

 

N+1 Singer (Nominated Adviser & Joint Broker)

Mark Taylor

Iqra Amin

 

020 7496 3000

Peel Hunt LLP (Joint Broker)

James Steel

Dr Christopher Golden

020 7418 8900

 

About ECO Animal Health

ECO Animal Health Group plc ("ECO" or "the GROUP") researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new product

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKALEDAFEEA
Date   Source Headline
8th Apr 20247:00 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSDisposal of non-core product line
22nd Mar 20247:00 amRNSShare Awards to Executive Directors
21st Mar 20249:13 amRNSReplacement: Trading Update
21st Mar 20247:00 amRNSTrading Update
19th Mar 20249:40 amRNSGeneral Meeting Result
27th Feb 20247:00 amRNSPublication of Notice of General Meeting
6th Feb 20247:00 amRNSTrademark Approval for ECOVAXXIN® family in the EU
8th Jan 20247:00 amRNSDisposal of Freehold Properties
5th Jan 20245:05 pmRNSHolding(s) in Company
5th Jan 20245:00 pmRNSHolding(s) in Company
22nd Dec 20237:00 amRNSDeferred Option Awards to Executive Directors
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
27th Nov 202310:00 amRNSInvestor Presentation
27th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
14th Nov 20233:00 pmRNSHolding(s) in Company
9th Nov 20237:00 amRNSCapital Markets Day Events
24th Oct 20237:00 amRNSNew USA and Canada label claim for Aivlosin®
28th Sep 20237:00 amRNSESG Rating
7th Sep 20232:57 pmRNSResult of AGM
10th Aug 20237:00 amRNSNotice of AGM
21st Jul 20234:25 pmRNSPosting of the Annual Report and Accounts
10th Jul 20237:00 amRNSFinal Results for the Year Ended 31 March 2023
5th Jul 20237:00 amRNSNotice of Results & Investor Presentation
6th Jun 20237:00 amRNSIssue of Equity and Total Voting Rights
18th May 20237:00 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSTrading Update
8th Mar 20237:00 amRNSAnimal Health Innovation Summit
27th Feb 202310:37 amRNSDirector/PDMR Shareholding
24th Feb 20233:19 pmRNSChange of Registered Address
17th Feb 20231:41 pmRNSHolding(s) in Company
13th Feb 20231:55 pmRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 20237:00 amRNSDirector/PDMR Shareholding
20th Jan 202312:14 pmRNSHolding(s) in Company
13th Dec 20223:50 pmRNSDeferred Share Option Awards
30th Nov 20223:01 pmRNSDirector/PDMR Shareholding
25th Nov 20221:37 pmRNSDirector/PDMR Shareholding
23rd Nov 20227:00 amRNSResults for the six months ended 30 September 2022
22nd Nov 20227:00 amRNSInvestor Presentation covering Interim Results
14th Nov 20227:00 amRNSChange of Auditor
31st Oct 20227:00 amRNSBlock listing Interim Review
24th Oct 20221:30 pmRNSHolding(s) in Company
24th Oct 20221:28 pmRNSHolding(s) in Company
26th Sep 20224:01 pmRNSResult of AGM
5th Sep 20221:00 pmRNSInvestor Presentation covering Full Year Results
2nd Sep 20227:00 amRNSPublication of Annual Report and Notice of AGM
31st Aug 20227:00 amRNSFinal Results for the Year Ended 31 March 2022
26th Aug 20221:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.